Home

Welcome to the Centre for Therapeutic Target Validation

For biomedical researchers who need to identify a biological target for a new therapy, the Centre for Therapeutic Target Validation (CTTV) is a public-private initiative to generate evidence on the validity of therapeutic targets based on genome-scale experiments and analysis. The CTTV is working to create an R&D framework that applies to a wide range of human diseases, and is committed to sharing its data openly with the scientific community.

News

Thursday, 27 March, 2014
A pioneering public-private research initiative between GSK, the European Bioinformatics Institute and the Wellcome Trust Sanger Institute is to harness the power of ‘big data’ and genome sequencing to improve the success rate for discovering new medicines. The new Centre for Therapeutic Target Validation will share its data openly in the interests of accelerating drug discovery.

Contact

image press@targetvalidation.org
image +44 (0)1223 494 665
image@targetvalidate

Jobs at the CTTV

Administration team, Wellcome Trust Sanger Institute

The postholder will liaise widely with the collaborators at the European Bioinformatics Institute and GlaxoSmithKline, the CTTV Operations Director and Finance Director as well as maintain internal relations with HR, Finance, Health and Safety and Regulatory and Science Admin (Grants and Ethical Compliance) teams within WTSI to ensure the smooth and timely delivery of these demanding and high visibility science projects for the CTTV collaboration.

Inflammatory bowel disease target validation, Wellcome Trust Sanger Institute

An exciting opportunity exists for an Advanced Research Assistant (ARA) to work on a multidisciplinary project that will identify and validate therapeutic targets for human inflammatory bowel diseases (IBD).

Inflammatory bowel disease target validation, Wellcome Trust Sanger Institute

We have an exciting opportunity for a Postdoctoral Fellow (PDF) to work on a multidisciplinary project that will identify and validate therapeutic targets for human inflammatory bowel diseases (IBD).

Atlas development team, EMBL-EBI

The successful candidate will play a crucial role in developing new user interfaces and data feeds to include the Expression Atlas tissue specificity of targets data within the CTTV web portal, and also allow users to explore their private data alongside the public data already in Atlas.

Web Development team, EMBL-EBI

The Web Developer’s primary role will be heading the design and development of web applications for the Centre for Therapeutic Target Validation (CTTV).

Reactome project, Proteomics Services Team, EMBL-EBI
The post involves further development/maintenance of core database applications and web services, web applications and data quality management systems. Reactome provides a curated database of human pathways (http://www.Reactome.org).